 Connor Clark Lunn Investment Management Ltd. bought a new stake in Catalyst Biosciences Inc NASDAQ:CBIO during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 63,992 shares of the biopharmaceutical companys stock, valued at approximately 280,000. A number of other large investors have also recently ... 